BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27913210)

  • 1. TRPV4 activation of endothelial nitric oxide synthase resists nonalcoholic fatty liver disease by blocking CYP2E1-mediated redox toxicity.
    Seth RK; Das S; Dattaroy D; Chandrashekaran V; Alhasson F; Michelotti G; Nagarkatti M; Nagarkatti P; Diehl AM; Bell PD; Liedtke W; Chatterjee S
    Free Radic Biol Med; 2017 Jan; 102():260-273. PubMed ID: 27913210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of high-intensity interval training and Iranian propolis extract on serum levels of TRPV4 and CYP2E1 proteins in patients with nonalcoholic fatty liver.
    Irandoust K; Gholamhosseini M; Samimi R; Dergaa I; Ben Saad H; Taheri M
    Tunis Med; 2024 Jan; 102(1):19-25. PubMed ID: 38545725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide donors prevent while the nitric oxide synthase inhibitor L-NAME increases arachidonic acid plus CYP2E1-dependent toxicity.
    Wu D; Cederbaum A
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):282-92. PubMed ID: 16938321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NKT cell modulates NAFLD potentiation of metabolic oxidative stress-induced mesangial cell activation and proximal tubular toxicity.
    Alhasson F; Dattaroy D; Das S; Chandrashekaran V; Seth RK; Schnellmann RG; Chatterjee S
    Am J Physiol Renal Physiol; 2016 Jan; 310(1):F85-F101. PubMed ID: 26447219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation into the antioxidant role of arginine in the treatment and the protection for intralipid-induced non-alcoholic steatohepatitis.
    Abu-Serie MM; El-Gamal BA; El-Kersh MA; El-Saadani MA
    Lipids Health Dis; 2015 Oct; 14():128. PubMed ID: 26463841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M1 polarization bias and subsequent nonalcoholic steatohepatitis progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1-induced oxidative stress in obese mice.
    Seth RK; Das S; Pourhoseini S; Dattaroy D; Igwe S; Ray JB; Fan D; Michelotti GA; Diehl AM; Chatterjee S
    J Pharmacol Exp Ther; 2015 Jan; 352(1):77-89. PubMed ID: 25347994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450-2E1 promotes fast food-mediated hepatic fibrosis.
    Abdelmegeed MA; Choi Y; Godlewski G; Ha SK; Banerjee A; Jang S; Song BJ
    Sci Rep; 2017 Jan; 7():39764. PubMed ID: 28051126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
    Pan ZG; An XS
    Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances.
    Abdelmegeed MA; Ha SK; Choi Y; Akbar M; Song BJ
    Curr Mol Pharmacol; 2017; 10(3):207-225. PubMed ID: 26278393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent endothelial functions of PIEZO1 and TRPV4 in hepatic portal vein and predominance of PIEZO1 in mechanical and osmotic stress.
    Endesh N; Chuntharpursat-Bon E; Revill C; Yuldasheva NY; Futers TS; Parsonage G; Humphreys N; Adamson A; Morley LC; Cubbon RM; Prasad KR; Foster R; Lichtenstein L; Beech DJ
    Liver Int; 2023 Sep; 43(9):2026-2038. PubMed ID: 37349903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts.
    Linhart K; Bartsch H; Seitz HK
    Redox Biol; 2014; 3():56-62. PubMed ID: 25462066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.
    Lieber CS
    Alcohol; 2004 Aug; 34(1):9-19. PubMed ID: 15670660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHIP(-/-)-Mouse Liver: Adiponectin-AMPK-FOXO-Activation Overrides CYP2E1-Elicited JNK1-Activation, Delaying Onset of NASH: Therapeutic Implications.
    Kim SM; Grenert JP; Patterson C; Correia MA
    Sci Rep; 2016 Jul; 6():29423. PubMed ID: 27406999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
    Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argininosuccinate synthase conditions the response to acute and chronic ethanol-induced liver injury in mice.
    Leung TM; Lu Y; Yan W; Morón-Concepción JA; Ward SC; Ge X; Conde de la Rosa L; Nieto N
    Hepatology; 2012 May; 55(5):1596-1609. PubMed ID: 22213272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol-Inducible Cytochrome P450-2E1-Mediated Oxidative and Nitrative Stress.
    Cho YE; Kim DK; Seo W; Gao B; Yoo SH; Song BJ
    Hepatology; 2021 Jun; 73(6):2180-2195. PubMed ID: 30959577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP14 governs CYP2E1 to promote nonalcoholic fatty liver disease through deubiquitination and stabilization of HSP90AA1.
    Wei D; Tian X; Zhu L; Wang H; Sun C
    Cell Death Dis; 2023 Aug; 14(8):566. PubMed ID: 37633951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.
    Bellanti F; Villani R; Facciorusso A; Vendemiale G; Serviddio G
    Free Radic Biol Med; 2017 Oct; 111():173-185. PubMed ID: 28109892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JIP3 knockout protects mice against high fat diet-induced liver injury.
    Ma XJ; Xing HZ; Ren GF; Rao XJ; Li ZZ
    Biochem Biophys Res Commun; 2018 Mar; 497(3):819-826. PubMed ID: 29454969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of cytochrome P450 2E1 [corrected] promotes liver injury in ob/ob mice.
    Dey A; Cederbaum AI
    Hepatology; 2007 Jun; 45(6):1355-65. PubMed ID: 17538970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.